119 related articles for article (PubMed ID: 23772643)
1. EVI1 targets platelet endothelial cell adhesion molecule and up-regulates its expression in chronic myeloid leukemia.
Pradhan AK; Chakraborty S
Leuk Lymphoma; 2014 Apr; 55(4):954-6. PubMed ID: 23772643
[No Abstract] [Full Text] [Related]
2. Activation of EVI1 transcription by the LEF1/β-catenin complex with p53-alteration in myeloid blast crisis of chronic myeloid leukemia.
Manachai N; Saito Y; Nakahata S; Bahirvani AG; Osato M; Morishita K
Biochem Biophys Res Commun; 2017 Jan; 482(4):994-1000. PubMed ID: 27908728
[TBL] [Abstract][Full Text] [Related]
3. [Clinical characteristics of childhood leukemia with EVI1 gene and BCR/ABL gene co-expression].
Jiang M; Li XQ; Hu D; Zhang ZQ; Yang YY; Bai LC; Jin RM
Zhongguo Dang Dai Er Ke Za Zhi; 2014 May; 16(5):489-93. PubMed ID: 24856998
[TBL] [Abstract][Full Text] [Related]
4. Philadelphia chromosome-positive chronic myeloid leukemia with p190(BCR-ABL) rearrangement, overexpression of the EVI1 gene, and extreme thrombocytosis: a case report.
Balatzenko G; Guenova M; Stoimenov A; Jotov G; Toshkov S
Cancer Genet Cytogenet; 2008 Feb; 181(1):75-7. PubMed ID: 18262061
[No Abstract] [Full Text] [Related]
5. EVI1 activation in blast crisis CML due to juxtaposition to the rare 17q22 partner region as part of a 4-way variant translocation t(9;22).
De Weer A; Poppe B; Cauwelier B; Carlier A; Dierick J; Verhasselt B; Philippé J; Van Roy N; Speleman F
BMC Cancer; 2008 Jul; 8():193. PubMed ID: 18613965
[TBL] [Abstract][Full Text] [Related]
6. Silencing of hsa-miR-124 by EVI1 in cell lines and patients with acute myeloid leukemia.
Vázquez I; Maicas M; Marcotegui N; Conchillo A; Guruceaga E; Roman-Gomez J; Calasanz MJ; Agirre X; Prosper F; Odero MD
Proc Natl Acad Sci U S A; 2010 Nov; 107(44):E167-8; author reply E169-70. PubMed ID: 20930122
[No Abstract] [Full Text] [Related]
7. 3q26/EVI1 rearrangements in myeloid hemopathies: a cytogenetic review.
De Braekeleer M; Le Bris MJ; De Braekeleer E; Basinko A; Morel F; Douet-Guilbert N
Future Oncol; 2015; 11(11):1675-86. PubMed ID: 26043219
[TBL] [Abstract][Full Text] [Related]
8. [Study of genes involved in chronic myeloid leukemia with t (3; 21) (q26; q22) in blastic crisis].
Liu XP; Zhang MR; Dai Y; Zhang L; Li R; Hao YS; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):310-3. PubMed ID: 16875579
[TBL] [Abstract][Full Text] [Related]
9. Both AML1 and EVI1 oncogenic components are required for the cooperation of AML1/MDS1/EVI1 with BCR/ABL in the induction of acute myelogenous leukemia in mice.
Cuenco GM; Ren R
Oncogene; 2004 Jan; 23(2):569-79. PubMed ID: 14724585
[TBL] [Abstract][Full Text] [Related]
10. The MDS and EVI1 complex locus (MECOM) isoforms regulate their own transcription and have different roles in the transformation of hematopoietic stem and progenitor cells.
Maicas M; Vázquez I; Alis R; Marcotegui N; Urquiza L; Cortés-Lavaud X; Cristóbal I; García-Sánchez MA; Odero MD
Biochim Biophys Acta Gene Regul Mech; 2017 Jun; 1860(6):721-729. PubMed ID: 28391050
[TBL] [Abstract][Full Text] [Related]
11. Ecotopic viral integration site 1 (EVI1) transcriptionally targets talin1 (TLN1) and upregulates its expression in chronic myeloid leukemia.
Halder A; Nayak KB; Chakraborty S
Leuk Lymphoma; 2018 Aug; 59(8):2008-2010. PubMed ID: 29214881
[No Abstract] [Full Text] [Related]
12. EVI1, BAALC and AME: prevalence of the secondary mutations in chronic and accelerated phases of chronic myeloid leukemia patients from eastern India.
Kuila N; Sahoo DP; Kumari M; Biswas S; Patnaik RS; Pattnayak NC; Biswas G; Chakraborty S
Leuk Res; 2009 Apr; 33(4):594-6. PubMed ID: 18752846
[No Abstract] [Full Text] [Related]
13. Genes break barrier between MDS and AML.
Haferlach C
Blood; 2015 Jan; 125(1):9-10. PubMed ID: 25554745
[No Abstract] [Full Text] [Related]
14. Dysregulated EVI1 expression in myeloid malignancies.
Pardanani A
Leuk Lymphoma; 2006 Dec; 47(12):2443-4. PubMed ID: 17169788
[No Abstract] [Full Text] [Related]
15. The shortest isoform of C/EBPβ, liver inhibitory protein (LIP), collaborates with Evi1 to induce AML in a mouse BMT model.
Watanabe-Okochi N; Yoshimi A; Sato T; Ikeda T; Kumano K; Taoka K; Satoh Y; Shinohara A; Tsuruta T; Masuda A; Yokota H; Yatomi Y; Takahashi K; Kitaura J; Kitamura T; Kurokawa M
Blood; 2013 May; 121(20):4142-55. PubMed ID: 23547050
[TBL] [Abstract][Full Text] [Related]
16. The role of EVI1 in myeloid malignancies.
Glass C; Wilson M; Gonzalez R; Zhang Y; Perkins AS
Blood Cells Mol Dis; 2014; 53(1-2):67-76. PubMed ID: 24495476
[TBL] [Abstract][Full Text] [Related]
17. Enhanced expression of the EVI1 gene in NUP98/HOXA-expressing leukemia cells.
Eguchi-Ishimae M; Eguchi M; Ohyashiki K; Yamagata T; Mitani K
Int J Hematol; 2009 Mar; 89(2):253-256. PubMed ID: 19241117
[No Abstract] [Full Text] [Related]
18. Improved classification of MLL-AF9-positive acute myeloid leukemia patients based on BRE and EVI1 expression.
Noordermeer SM; Monteferrario D; Sanders MA; Bullinger L; Jansen JH; van der Reijden BA
Blood; 2012 May; 119(18):4335-7. PubMed ID: 22555662
[No Abstract] [Full Text] [Related]
19. Reverse transcriptase-polymerase chain reaction based quantification of the combined MDS-EVI1/EVI1 gene in acute myeloid leukemia.
Weisser M; Kern W; Schoch C; Tschulik C; Hiddemann W; Haferlach T; Schnittger S
Leuk Lymphoma; 2006 Dec; 47(12):2645-7. PubMed ID: 17169810
[No Abstract] [Full Text] [Related]
20. Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia.
Cuenco GM; Ren R
Oncogene; 2001 Dec; 20(57):8236-48. PubMed ID: 11781838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]